-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nivolumab in Pleomorphic Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nivolumab in Pleomorphic Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nivolumab in Pleomorphic Liposarcoma Drug Details: Nivolumab (Opdivo, Opdyta) is a...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BNC-210 in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BNC-210 in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BNC-210 in Post-Traumatic Stress Disorder (PTSD) Drug Details: BNC-210 (IW-2143)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NLG-207 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NLG-207 in Small-Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NLG-207 in Small-Cell Lung Cancer Drug Details: NLG-207 (CRLX-101) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – XL-888 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - XL-888 in Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. XL-888 in Colorectal Cancer Drug Details: XL-888 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MEDI-1191 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. MEDI-1191 in Solid Tumor Drug Details: MEDI-1191 (mRNA-2905) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SL-172154 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SL-172154 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SL-172154 in Metastatic Ovarian Cancer Drug Details: SL-172154 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexmarilimab in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexmarilimab in Metastatic Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexmarilimab in Metastatic Melanoma Drug Details: Bexmarilimab is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketamine Hydrochloride in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ketamine Hydrochloride in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ketamine Hydrochloride in Post-Traumatic Stress Disorder (PTSD) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PD-0360324 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PD-0360324 in Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PD-0360324 in Ovarian Cancer Drug Details: PD-360324 is under development for treatment...